Lv7
5000 积分 2023-10-08 加入
Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction
6天前
已完结
Open Targets: 10 years of partnership in target discovery
9天前
已完结
DDAVP in the Treatment of Central Diabetes Insipidus
19天前
已完结
Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
27天前
已关闭
Omalizumab-induced reductions in mast cell FcεRI expression and function
27天前
已完结
Update on Omalizumab for Urticaria: What’s New in the Literature from Mechanisms to Clinic
27天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1个月前
已完结
First-in-class APRIL inhibitor secures approval for rare kidney disease
2个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
2个月前
已完结
A Preliminary Quality of Life Questionnaire-Bronchiectasis
2个月前
已完结
The Theory and Practice of Genome Sequence Assembly
皖公网安备34019202002308
